Corporate Headquarters

 

Injectsense, Inc.
2000 Powell St

Suite 1425 
Emeryville, CA 94608

 

(510) 292-4120
 

 

 

Twin Cities

 

Injectsense, Inc.

7825 Washington Ave. South

Suite 650

Minneapolis, MN 55439

 

 

 

 

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Facebook Social Icon

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

INVESTORS

INVESTORS

TECHNOLOGY

RESOURCES

RESOURCES

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

RESOURCES

RESOURCES

1/5

Improved Therapy Through Continuous Information  

 

Find out how we are transforming the industry by providing continuous, clinically actionable information

 

 

 

 

News

 

 

     InjectSense Opens Palo Alto Engineering Office

 

     InjectSense Tapes Out First Silicon for Ultra-Low Power ASIC Blocks

 

     InjectSense Announces Medical Board of Advisors

Careers

Emeryville  |  Palo Alto  |  Twin Cities

To be replaced by better photo

of finger/device

Technology

 

Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.

Investors

InjectSense is funded by angel groups and private investors. It generates revenue from joint development projects with strategic market players, based on derived products from its core sensing technology platform. The company is currently coordinating Series A funding.

Events

 

COMS Conference

August 28-31, 2016 

Houston

 

Medica

November 14-17, 2016

Dusseldorf

 

 

 

 

The InjectSense Difference

 

Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise. 

CAUTION - Investigational Device. Limited by Federal law to investigational use.